The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 2710
Special Issue Editors
Interests: sarcoidosis; granuloma; hypoxia; interstitial lung disease; fibrosis; macrophages
Interests: sarcoidosis; granuloma; interstitial lung disease; fibrosis; immunoregulation; T cells
Special Issue Information
Dear Colleagues,
Sarcoidosis is a rare systemic granulomatous disease of unknown cause(s) that initiates in genetically predisposed individuals a disproportionate inflammatory response leading to granuloma formation. For most patients, spontaneous resolution or short courses of glucocorticoids will take place; however, absence of response to existing lines of treatment will lead to a reduced quality of life with dyspnea, fatigue, and severe disabilities associated with pulmonary, cardiac, and nervous system impairment. Both the innate and adaptive immune systems are involved in sarcoidosis pathogenesis. Factors influencing the disease course towards clinical resolution versus chronic disease and fibrosis remain unknown and represent major targets for the development of new treatment strategies to replace/enhance current therapies, including steroids and/or biologic agents. Identification of new mechanisms in the pathogenesis of sarcoidosis should help us to better understand the variability in disease course amongst patients and to develop more effective treatments for sarcoidosis.
Dr. Valérie BesnardGuest Editor
Dr. Makoto Miyara
Co-Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcoidosis
- granulomatosis
- genetics
- environment
- immunopathology
- models
- corticosteroids
- biologic treatments
